Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST) [Phase 2]
A Phase 2 clinical trial (GEM-AnitoFIRST) is evaluating the efficacy and safety of Anitocabtagene Autoleucel in participants with newly diag…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
A safety study of Empliciti (elotuzumab) in patients with multiple myeloma in Taiwan has completed.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]
Phase 1 imaging trial evaluating 64Cu-LLP2A in hematologic malignancies is currently recruiting, targeting multiple myeloma and various lymp…
-
CLINICAL_TRIALS other · 2025-07-29Clinical Trial Update: A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update describes GR1803 Injection combined with an anti-CD38 monoclonal antibody for treating multiple myel…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating ST-067 in combination with Teclistamab for relapsed or refractory multiple myeloma has been terminated. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) [NA]
Clinical trial update for ACT evaluating compassionate communication and advance care planning to improve end-of-life care in hematologic di…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
This clinical trial update describes a study evaluating positron emission tomography with innovative laboratory techniques to improve risk a…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients [NA]
A clinical trial update notes an active, non-recruiting study evaluating a mobile app for education based on Orem's Self-Care Model in patie…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma [NA]
This clinical trial update examines two methods for collecting electronic patient-reported outcomes in patients with multiple myeloma. The s…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
This clinical trial update assesses the immune response to an RSV vaccine in patients with hematologic cancers, including multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence [Phase 1, Phase 2]
A Phase 1/2 trial of checkpoint inhibition after autologous stem cell transplantation for patients at high risk of post-transplant recurrenc…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM [Phase 1, Phase 2]
A clinical trial update describes a sub-study of belantamab mafodotin in combination with nirogacestat for relapsed and refractory multiple …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research [EARLY_Phase 1]
This document reports an EARLY Phase 1 clinical trial evaluating Meta10-BCMA for relapsed/refractory plasma cell neoplasms. The therapy uses…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells [Phase 1]
Phase 1 trial evaluating cyclosporine in combination with carfilzomib and dexamethasone in patients with relapsed or refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating BCMA-targeted LCAR-BCDR Cells in patients with relapsed/refractory multiple myeloma has been terminated …
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI [NA]
A clinical trial evaluating noninvasive whole-body MRI to detect and monitor therapy response in multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib [Phase 2]
Phase 2 trial evaluating ixazomib-pomalidomide-dexamethasone as second or third-line treatment for relapsed and refractory multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma [Phase 3]
A Phase 3 prospective comparison of 18F-choline PET/CT versus 18F-FDG PET/CT for the initial work-up of multiple myeloma. The trial status i…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant [NA]
This study update notes that a trial investigating cognitive outcomes in older adults receiving stem cell transplant is currently in RECRUIT…
-
EMA approval · 2025-07-22EMA Authorised: Lynozyfic (linvoseltamab) — Regeneron Ireland Designated Activity Company (DAC)
EMA authorised Lynozyfic (linvoseltamab) for multiple myeloma with conditional approval; Regeneron Ireland DAC is the marketing authorisatio…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) [Phase 3]
A Phase III clinical trial evaluating Eque-cel for len-refractory relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]
This document reports the completion of a Phase I clinical trial of Y150 in relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM [Phase 2]
Phase 2 trial evaluating subcutaneous daratumumab with dose-attenuated bortezomib, lenalidomide, and dexamethasone in elderly patients with …
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid [NA]
This document reports that Washington University School of Medicine is implementing a randomized controlled trial to evaluate an expanded we…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Multiple Myeloma Yoga Pilot Study [NA]
A pilot study evaluating yoga for individuals with multiple myeloma has completed, sponsored by the University of Arizona.